01
Market Access Foundations
Build the foundation for a career in Market Access.
For pharmaceutical professionals who want to understand the discipline properly and build the knowledge needed to begin an Access career.
MENA Market Access Academy
First 2027 cohort begins January 2027
Don't just learn Market Access. Learn how to think like an Access professional.
Understand value. Navigate healthcare systems. Build access strategies. Develop the capabilities that can take your pharmaceutical career further.
MEAXS provides structured professional development for people who want to build serious capability in pharmaceutical Market Access.
Why Market Access
Market Access sits at the intersection of medicine, healthcare systems, economics, strategy and business. It asks some of the most important questions in healthcare.
For ambitious pharmaceutical professionals, understanding these questions can open an entirely different perspective on the industry.
What MEAXS develops
A strong Market Access professional connects many disciplines. Select any capability to see what it depends on.
The objective is not to memorize Market Access terminology. It is to learn how the pieces connect.
16 capabilities / 3 programs
The programs
From understanding how Access works, to doing it, to leading it. Each program is a structured cohort journey with its own certificate.
01
Build the foundation for a career in Market Access.
For pharmaceutical professionals who want to understand the discipline properly and build the knowledge needed to begin an Access career.
02
Move from understanding Access to doing Access.
For professionals who already know the basic concepts and want practical capability, built through realistic pharmaceutical situations and cases.
03
Learn to think and operate like an Access leader.
The advanced MEAXS journey, for experienced Access professionals and high-potential colleagues preparing for greater strategic responsibility. May extend over several months.
The learning philosophy
MEAXS programs are designed as structured learning journeys, not collections of recorded lectures.
Participants learn through live teaching, discussion, pharmaceutical cases, problem solving, exercises, assignments, feedback and assessment.
Depending on the program, learning may be delivered face-to-face, virtually, or in a blended format. Programs extend over several weeks, and advanced journeys may continue for several months.
The goal is not simply to know more. The goal is to think differently, ask better questions, make stronger decisions and become more capable.
Career value
MEAXS is designed for professionals who want to become stronger candidates for Market Access opportunities and more capable contributors within the pharmaceutical industry.
Participants develop knowledge and thinking that can strengthen
A certificate can demonstrate that you completed the program. Your capability should demonstrate what you learned from it.
Certification
Participants who successfully complete the requirements of their program receive a MEAXS certificate for that program.
Certificates are awarded on completion of program requirements, including assessment. MEAXS certificates are professional certificates and are not academic qualifications.
Selective admission
MEAXS programs are cohort-based and places are limited. Applicants submit their details and CV. Selected candidates may be invited to a short online interview about their experience, career objectives and commitment to the program.
The objective is to build cohorts of participants who genuinely want to develop.
Tell us about your experience and what you want to achieve.
We look at your experience and objectives.
A brief online conversation with selected candidates.
Including schedule, format and program investment.
Only once you have all the details.
First cohortJan 2027
January 2027 Cohort
Applications for priority consideration are now open.
Programs will be delivered through selected virtual, face-to-face and blended formats. Detailed schedules, locations and program investment will be shared as enrollment progresses, and always before you make any commitment.
Apply for Priority ConsiderationInsights
Short, practical pieces on how Market Access actually works.
All insightsPrice is the most visible lever, so it gets blamed first. It is often the wrong diagnosis.
ReadTwo questions every payer asks, and why a good answer to one does not answer the other.
ReadFewer questions than you think, and none of them are about your brand messages.
ReadFor pharmaceutical organizations
MEAXS designs customized capability-building programs, workshops and cohort-based learning journeys for pharmaceutical organizations across MENA.